Skip to content
EB

Updated:

Edge BioSystems

A CALIBRE SCIENTIFIC COMPANY | EdgeBio has a team of experienced research professionals that are knowledgeable in next generation sequencing technologies and...

Overview

A CALIBRE SCIENTIFIC COMPANY | EdgeBio has a team of experienced research professionals that are knowledgeable in next generation sequencing technologies and applications. From library preparation through data analysis, EdgeBio representatives are there to discuss your project on a custom basis to ensure that you receive the results you need for your research.

General information

Location

Region

North America

Country

United States

City

Gaithersburg

Corporate office

Gaithersburg, MD, United States

Sector focus

Healthcare ServicesAgriTech & FoodTech

Frequently asked questions

Who runs investment decisions at Edge BioSystems?

The principals or investment decision-makers at Edge BioSystems are not publicly disclosed. The firm does not list a management team or board on its website or in public records. Allocators seeking this information should contact the firm directly.

What is Edge BioSystems' known posture on co-investments?

There is no public information about Edge BioSystems' involvement in co-investments or partnerships with external investors. The firm does not disclose its investment strategy or deal structures.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Explore more profiles